Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of the TRAIN-AI Score for the Prediction of Hepatocellular Carcinoma Recurrence After Liver Transplantation

NCT06799468 is registered in ClinicalTrials.gov with European Hepatocellular Cancer Liver Transplant Group as lead sponsor.

NCT NCT06799468
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06799468 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of the TRAIN-AI Score for the Prediction of Hepatocellular Carcinoma Recurrence After Liver Transplantation
Lead sponsor
European Hepatocellular Cancer Liver Transplant Group
Phase
Observational
Overall status
Completed
Start date
January 1, 2003
Completion date
December 31, 2018
Enrollment
1,769 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

deep learning model, hepatocellular carcinoma (hcc), liver transplantation